KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

IonQ (IONQ) Research & Development (2020 - 2025)

IonQ has reported Research & Development over the past 6 years, most recently at $96.1 million for Q4 2025.

  • Quarterly results put Research & Development at $96.1 million for Q4 2025, up 139.78% from a year ago — trailing twelve months through Dec 2025 was $305.7 million (up 123.42% YoY), and the annual figure for FY2025 was $305.7 million, up 123.42%.
  • Research & Development for Q4 2025 was $96.1 million at IonQ, up from $66.3 million in the prior quarter.
  • Over the last five years, Research & Development for IONQ hit a ceiling of $103.4 million in Q2 2025 and a floor of $3.7 million in Q1 2021.
  • Median Research & Development over the past 5 years was $22.2 million (2023), compared with a mean of $30.0 million.
  • Peak annual rise in Research & Development hit 231.24% in 2025, while the deepest fall reached 23.43% in 2025.
  • IonQ's Research & Development stood at $4.9 million in 2021, then skyrocketed by 178.54% to $13.7 million in 2022, then soared by 130.87% to $31.6 million in 2023, then increased by 26.75% to $40.1 million in 2024, then skyrocketed by 139.78% to $96.1 million in 2025.
  • The last three reported values for Research & Development were $96.1 million (Q4 2025), $66.3 million (Q3 2025), and $103.4 million (Q2 2025) per Business Quant data.